BioSpace News Archive

Commits $2.5 million to support University of Toronto’s Creative Destruction Lab Health Stream

YOFOTO (China) Health and RepliCel Life Sciences finalize investment and commence collaboration activity in Greater China

One-Year Results from Phase 2 Study Evaluating STELARA® (ustekinumab) in Patients with Active Systemic Lupus Erythematosus Featured in a Plenary Presentation

Immunomic Therapeutics, Inc. announced today that the company will present at the 2018 BIO Investor Forum being held in San Francisco, CA on October 17-18.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announce the signing of an expanded global collaboration agreement that will strengthen the relationship between the two companies for the further development and commercialization of a portfolio of medicines including the ABILIFY MYCITE® (aripiprazole tablets with sensor) offering, which received NDA approval from the U.S. Food and Drug Administration in November 2017.

Tc 99m tilmanocept is the first product developed and commercialized by the Company based on the Manocept platform.

VBL is developing its VB-600 platform of biologics targeting MOSPD2 for inflammatory and oncology indications.

Created by Baby Einstein founder Julie Clark, the WeeSchool App combines child development information, tips and activities for daily play, music, eBooks and visual content for babies and toddlers with an easy-to-follow, research-based curriculum for parents.

The Retia Argos Cardiac Output Monitor, which provides superior accuracy for hemodynamic monitoring, will be previewed at ANESTHESIOLOGY® 2018

TORONTO, /CNW/ - The University of Toronto Mississauga (UTM), in collaboration with the Amgen Foundation and Amgen Canada, is helping transform local science education and ignite a life-long love of science in students in schools across the Greater Toronto Area (GTA).